iBio, Inc.
(NYSE Amex Equities : IBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.49%331.970.0%$4431.16m
BNTXBioNTech SE 2.15%268.500.0%$738.75m
NVAXNovavax, Inc. -15.16%136.2179.4%$603.27m
AMGNAmgen, Inc. 1.57%210.041.4%$554.93m
SNSSSunesis Pharmaceuticals, Inc. 4.56%6.420.7%$448.78m
REGNRegeneron Pharmaceuticals, Inc. 1.70%561.502.7%$438.92m
GILDGilead Sciences, Inc. 0.37%67.151.0%$414.60m
CCXIChemoCentryx, Inc. 2.82%34.602.9%$396.23m
ILMNIllumina, Inc. -0.10%413.653.3%$374.23m
XLRNAcceleron Pharma, Inc. -0.43%173.005.3%$348.83m
VRTXVertex Pharmaceuticals, Inc. 0.39%186.131.9%$270.81m
BIIBBiogen, Inc. -0.52%266.751.7%$242.28m
OCGNOcugen, Inc. 4.20%8.680.0%$183.83m
XENEXenon Pharmaceuticals, Inc. 2.01%30.410.4%$163.60m
CRSPCRISPR Therapeutics AG -1.49%98.770.6%$159.71m

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the Biopharmaceuticals and Bioprocessing segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX.